Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy.

Patrizii M, Bartucci M, Pine SR, Sabaawy HE.

Front Oncol. 2018 Feb 12;8:23. doi: 10.3389/fonc.2018.00023. eCollection 2018.

2.

Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma.

Haas TL, Sciuto MR, Brunetto L, Valvo C, Signore M, Fiori ME, di Martino S, Giannetti S, Morgante L, Boe A, Patrizii M, Warnken U, Schnölzer M, Ciolfi A, Di Stefano C, Biffoni M, Ricci-Vitiani L, Pallini R, De Maria R.

Cell Stem Cell. 2017 Jul 6;21(1):35-50.e9. doi: 10.1016/j.stem.2017.04.009. Epub 2017 Jun 9.

3.

Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.

Bartucci M, Hussein MS, Huselid E, Flaherty K, Patrizii M, Laddha SV, Kui C, Bigos RA, Gilleran JA, El Ansary MMS, Awad MAM, Kimball SD, Augeri DJ, Sabaawy HE.

Target Oncol. 2017 Aug;12(4):449-462. doi: 10.1007/s11523-017-0501-x.

PMID:
28589491
4.

BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.

Bansal N, Bartucci M, Yusuff S, Davis S, Flaherty K, Huselid E, Patrizii M, Jones D, Cao L, Sydorenko N, Moon YC, Zhong H, Medina DJ, Kerrigan J, Stein MN, Kim IY, Davis TW, DiPaola RS, Bertino JR, Sabaawy HE.

Clin Cancer Res. 2016 Dec 15;22(24):6176-6191. doi: 10.1158/1078-0432.CCR-15-3107. Epub 2016 Jun 15.

5.

A microRNA code for prostate cancer metastasis.

Bonci D, Coppola V, Patrizii M, Addario A, Cannistraci A, Francescangeli F, Pecci R, Muto G, Collura D, Bedini R, Zeuner A, Valtieri M, Sentinelli S, Benassi MS, Gallucci M, Carlini P, Piccolo S, De Maria R.

Oncogene. 2016 Mar 3;35(9):1180-92. doi: 10.1038/onc.2015.176. Epub 2015 Jun 15.

6.

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R.

Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17.

PMID:
24531710
7.

Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.

Fiori ME, Barbini C, Haas TL, Marroncelli N, Patrizii M, Biffoni M, De Maria R.

Cell Death Differ. 2014 May;21(5):774-82. doi: 10.1038/cdd.2014.6. Epub 2014 Jan 31.

8.

Approaching the increasing complexity of non-small cell lung cancer taxonomy.

Maugeri-Sacca M, Bartucci M, Pagliuca A, Patrizii M, Signore M, De Maria R.

Curr Pharm Des. 2014;20(24):3973-81. Review.

PMID:
24138717
9.

Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells.

Chimento A, Casaburi I, Bartucci M, Patrizii M, Dattilo R, Avena P, Andò S, Pezzi V, Sirianni R.

Cell Death Dis. 2013 Aug 1;4:e747. doi: 10.1038/cddis.2013.275.

10.

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

Francescangeli F, Patrizii M, Signore M, Federici G, Di Franco S, Pagliuca A, Baiocchi M, Biffoni M, Ricci Vitiani L, Todaro M, De Maria R, Zeuner A.

Stem Cells. 2012 Sep;30(9):1819-30. doi: 10.1002/stem.1163.

11.

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.

Coppola V, Musumeci M, Patrizii M, Cannistraci A, Addario A, Maugeri-Saccà M, Biffoni M, Francescangeli F, Cordenonsi M, Piccolo S, Memeo L, Pagliuca A, Muto G, Zeuner A, De Maria R, Bonci D.

Oncogene. 2013 Apr 4;32(14):1843-53. doi: 10.1038/onc.2012.194. Epub 2012 May 21.

PMID:
22614007
12.

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-Saccà M, Eramo A, De Maria R.

Cell Death Differ. 2012 May;19(5):768-78. doi: 10.1038/cdd.2011.170. Epub 2011 Nov 25.

13.

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.

Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Saccà M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D'Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D.

Oncogene. 2011 Oct 13;30(41):4231-42. doi: 10.1038/onc.2011.140. Epub 2011 May 2.

PMID:
21532615
14.

Oxytetracycline as environmental contaminant in arable lands.

Brambilla G, Patrizii M, De Filippis SP, Bonazzi G, Mantovi P, Barchi D, Migliore L.

Anal Chim Acta. 2007 Mar 14;586(1-2):326-9. Epub 2006 Nov 11.

PMID:
17386731

Supplemental Content

Loading ...
Support Center